I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 8 studies | 28% ± 12% | |
| macrophage | 8 studies | 21% ± 2% | |
| fibroblast | 7 studies | 21% ± 6% | |
| classical monocyte | 6 studies | 23% ± 8% | |
| natural killer cell | 6 studies | 17% ± 2% | |
| conventional dendritic cell | 5 studies | 26% ± 9% | |
| monocyte | 5 studies | 20% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 2% | |
| CD8-positive, alpha-beta T cell | 4 studies | 18% ± 3% | |
| epithelial cell | 4 studies | 25% ± 6% | |
| CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| dendritic cell | 3 studies | 40% ± 11% | |
| mononuclear phagocyte | 3 studies | 24% ± 8% | |
| connective tissue cell | 3 studies | 24% ± 7% |
